Skip to main content
Clinical Trials/JPRN-UMIN000001138
JPRN-UMIN000001138
Completed
Phase 1

A randomized controlled trial of intra-arterial infusion of CDDP for hepatocellular carcinoma to prevent intra-hepatic metastasis after curative resection - Efficacy of intra-arterial infusion of CDDP after curative resection of hepatocellular carcinoma

iigata Hepatocellular Carcinoma Therapy Study Group0 sites200 target enrollmentMay 1, 2008

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Patients after curative resection of hepatocellular carcinoma
Sponsor
iigata Hepatocellular Carcinoma Therapy Study Group
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2008
End Date
April 1, 2015
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
iigata Hepatocellular Carcinoma Therapy Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. The history of severe allergic reaction against iodinated contrast medium and/or platinum\-containing drugs. 2\. A woman who is pregnant, lactating, or may become pregnant. 3\. Hepatocellular carcinoma extended to the first branch of the portal vein or further. 4\. Hepatocellular carcinoma extended to the inferior vena cava or further. 5\. Dynamic CT or dynamic MRI revealed that hepatocellular carcinoma is solitary and 2 cm or less without vascular invasion. 6\. Under interferon therapy. 7\. A doctor responsible for the study judged to be inappropriate.

Outcomes

Primary Outcomes

Not specified

Similar Trials